The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.2(PAH):c.511G>A (p.Gly171Arg)

CA229598

102716 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 0dbfb1dc-9c9b-4fbe-b1a1-37b190aafe51

HGVS expressions

NM_000277.2:c.511G>A
NM_000277.2(PAH):c.511G>A (p.Gly171Arg)
NC_000012.12:g.102855331C>T
CM000674.2:g.102855331C>T
NC_000012.11:g.103249109C>T
CM000674.1:g.103249109C>T
NC_000012.10:g.101773239C>T
NG_008690.1:g.67272G>A
NG_008690.2:g.108080G>A
NM_000277.1:c.511G>A
NM_001354304.1:c.511G>A
NM_000277.3:c.511G>A
ENST00000307000.7:c.496G>A
ENST00000549111.5:n.607G>A
ENST00000551988.5:n.532G>A
ENST00000553106.5:c.511G>A

Likely Pathogenic

Met criteria codes 4
PP4_Moderate PM3_Strong PM2 PP3

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP3: Deleterious effect predicted in SIFT, Polyphen-2, MutationTaster. REVEL=0.966; PP4_Moderate: Detected in PKU patients. BH4 deficiency assessed. Upgraded per ClinGen PAH EP. (PMID:26600521; PMID:23430918); PM3_Strong: Detected with c.611A>G (P/LP) and R408W (P). Upgraded per ClinGen SVI workgroup. (PMID:23430918; PMID:26600521). In summary this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate, PM3_Strong).
Met criteria codes
PP4_Moderate
Detected in PKU patients. BH4 deficiency assessed. Upgraded per ClinGen PAH EP.

PM3_Strong
Detected with c.611A>G (P/LP) and R408W (P). Upgraded per ClinGen SVI workgroup.

PM2
Absent from ExAC, gnomAD, 1000G, ESP
PP3
Deleterious effect predicted in SIFT, Polyphen-2, MutationTaster. REVEL=0.966
Approved on: 2018-08-10
Published on: 2019-05-04
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.